Nieves Martínez Chanzá

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

Nieves Martínez Chanzá, Wanling Xie, Mehmet Asım Bilen et al. · The Lancet Oncology · 2019 · 175 citations

Medicine, Oncology, Pharmacology +11

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma

Sarah Abou Alaiwi, Saud H. AlDubayan, Nicholas Moore et al. · Genetics in Medicine · 2019 · 113 citations · Full text

Medicine, Genetics, Oncology +17

Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma

Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah et al. · JAMA Oncology · 2021 · 95 citations · Full text

Medicine, Oncology, Pharmacology +17

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma

Sarah Abou Alaiwi, Wanling Xie, Amin H. Nassar et al. · Journal for ImmunoTherapy of Cancer · 2020 · 84 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy of Cabozantinib in Metastatic MiT Family Translocation Renal Cell Carcinomas

Jonathan Thouvenin, Omar Alhalabi, Maria I. Carlo et al. · The Oncologist · 2022 · 37 citations · Full text

Medicine, Oncology, Pharmacology +14